menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

Entos

Develops small-molecule therapeutics using AI-driven platform that combines physics-based algorithms with experimental testing

Enveda Biosciences

Biotech company uses AI to analyze natural compounds and discover new drugs, transforming plant-based molecules into potential medicines.

Enveda Biosciences

Uses AI to analyze natural compounds and discover new drugs, transforming plant-based molecules into potential medicines.

Epic Bio

Develops epigenetic engineering therapies to modulate gene expression without DNA modification, using compact CRISPR delivery systems.

Expansion Therapeutics

Biotech company develops oral medicines targeting RNA to treat neurological disorders using small molecule technology.

Expedition

Creates oral treatments that modulate neutrophilic inflammation to address COPD and various respiratory conditions.

EXUMA Biotech

Develops gene vector delivery platforms to make cell and gene therapies more accessible, cost-effective, and safer for patients.

Faraday Pharmaceuticals

Develops treatments to prevent heart failure by reducing myocardial damage following acute STEMI.

Flare Therapeutics

A biotechnology company that develops precision medicines by targeting transcription factors, aiming to treat diseases such as cancer through innovative approaches.

FogPharma

Develops ultra-tunable peptide therapeutics.

Galaxy Diagnostics

Offer tests that detect flea- and tick-borne pathogens in people and animals with enhanced accuracy and diagnostic support.

Geltor

Animal-free, category-defining ingredients.

GeneCentric Therapeutics

Utilizes a unique partnership model to translate important cancer discoveries into clinically adopted diagnostics for pathologists, clinicians, and patients.

Geneoscopy

Develops diagnostic tests for gastrointestinal health using RNA technology to enable noninvasive screening for colorectal diseases.

Generate Biomedicines-Logo

Generate Biomedicines

Generative biology company with a revolutionary approach to drug development.

Genesis Therapeutics

Engages proprietary molecular AI to discover and develop small molecule drugs for severe disorders.

Genotix

Develops ultrasensitive nanoarray technology for single-molecule biomarker detection, enabling early disease identification and health monitoring.

GentiBio

Develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases using proprietary technology platform.